← FDA DRUG APPROVALS

FDA ANDA · ANDA071178

CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE

Sponsor: PAR PHARM

APPLICATION
ANDA071178
TYPE
ANDA
ORIGINAL APPROVAL
1987-12-16
LATEST ACTION
1997-11-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONEDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.2MG · TABLET · ORAL

Approval history

1997-11-26Manufacturing (CMC) · Supplement 11AP
1997-11-26Manufacturing (CMC) · Supplement 10AP
1994-08-24Manufacturing (CMC) · Supplement 9AP
1988-04-25Manufacturing (CMC) · Supplement 6AP
1988-04-25Manufacturing (CMC) · Supplement 5AP
1988-04-01Manufacturing (CMC) · Supplement 2AP
1987-12-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →